Skip Nav Destination
Article navigation
Meeting Abstracts|
April 2001
PHOSPHODIESTERASE (PDE5) PLACENTAL RECEPTOR INHIBITION OBTUNDS HYPOXIC FETOPLACENTAL VASOCONSTRICTION (HFPV) IN THE HUMAN PLACENTA. : A51 (Poster 41)
Anesthesiology, Vanderbilt University, Nashville, TN
Anesthesiology April 2001, Vol. 94, NA.
Citation
J. W. Downing, B. H. Minzter, R. Ramasubramanian, R. L. Paschall, J. J. York, R. F. Johnson; PHOSPHODIESTERASE (PDE5) PLACENTAL RECEPTOR INHIBITION OBTUNDS HYPOXIC FETOPLACENTAL VASOCONSTRICTION (HFPV) IN THE HUMAN PLACENTA. : A51 (Poster 41). Anesthesiology 2001; 94:NA doi: https://doi.org/10.1097/00000542-200104001-00051
Download citation file:
Citing articles via
Most Viewed
Related Articles
Sildenafil Is a Pulmonary Vasodilator in Awake Lambs with Acute Pulmonary Hypertension
Anesthesiology (June 2000)
PHOSPHODIESTERASE (PDE5) RECEPTOR INHIBITION MODERATES THE VASOPRESSOR EFFECT OF 5-HYDROXYTRPTAMINE (5-HT) ON THE FETOPLACENTAL VASCULATURE. : A50 (Poster 40)
Anesthesiology (April 2001)
Sodium Nitroprusside (SNP) Obtunds The Vasopressor Action Of 5-Hydroxytrptamine (5-HT) On The Placental Intravillous Circulation : A107 (Poster 66)
Anesthesiology (April 2000)
SODIUM NITROPRUSSIDE (SNP) INHIBITS HYPOXIC FETO-PLA CENTAL VASOCONSTRICTION (HFPV) IN THE DUAL PERFUSED, SINGLE ISOLATED HUMAN PLACENTAL COTYLEDON : P-90
Anesthesiology (April 2002)
Anesthesia Sensitivity in Mice that Lack the β3 Subunit of the γ-Aminobutyric Acid Type A Receptor
Anesthesiology (March 1998)